What is Uxin Ltd.'s earnings per share (EPS)?

Uxin Ltd. (UXIN) reported diluted earnings per share of $0.00 for fiscal year 2025. This represents a 100.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Uxin Ltd. Financials

UXIN

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Uxin Ltd. (UXIN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI UXIN FY2024 2026-04-22

Uxin’s low-gross-margin resale model still depends on external financing because operations do not cover overhead and cash burn.

From FY2023 to FY2024, gross margin expanded from 1.2% to 5.9%, showing better unit economics on each sale. But free cash burn stayed near last year's level at -$38.1M as interest expense climbed to $8.7M, so better markup did not make the business self-funding.

The balance sheet is short-term constrained: cash ended FY2024 at $3.2M against current liabilities of $122.6M, leaving little room for operating volatility. Because operations used -$36.3M of cash, the $28.4M financing inflow functioned more like refill capital than optional growth funding.

Working capital pressure is not mainly a collections problem: receivables were just $289K against revenue of $190.4M, implying customers pay quickly or before long credit terms build up. Inventory at $15.3M therefore matters more than receivables, which fits an inventory-led operating model where holding stock and covering fixed overhead drive results.

Financial Health Signals

Financial Profile 14/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Uxin Ltd.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Uxin Ltd. has an operating margin of -5.4%, meaning the company retains $-5 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -22.7% the prior year.

Growth

Uxin Ltd.'s revenue surged 143.3% year-over-year to $463.3M, reflecting rapid business expansion. This strong growth earns a score of 74/100.

Leverage

Uxin Ltd. has elevated debt relative to equity (D/E of -10.02), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

Uxin Ltd.'s current ratio of 0.76 is below the typical benchmark, resulting in a score of 10/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

While Uxin Ltd. generated -$72.1M in operating cash flow, capex of $3.1M consumed most of it, leaving -$75.2M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Piotroski F-Score Neutral

4/9

Uxin Ltd. passes 4 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality

1.92x

For every $1 of reported earnings, Uxin Ltd. generates $1.92 in operating cash flow (-$72.1M OCF vs -$37.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-1.8x

Uxin Ltd. earns $-1.8 in operating income for every $1 of interest expense (-$24.8M vs $13.5M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$463.3M

YoY+143.3%

5Y CAGR+15.3%

Uxin Ltd. generated $463.3M in revenue in fiscal year 2025. This represents an increase of 143.3% from the prior year.

EBITDA

-$15.9M

YoY+61.7%

Uxin Ltd.'s EBITDA was -$15.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 61.7% from the prior year.

Net Income

-$37.5M

YoY+27.2%

Uxin Ltd. reported -$37.5M in net income in fiscal year 2025. This represents an increase of 27.2% from the prior year.

EPS (Diluted)

$0.00

YoY+100.0%

Uxin Ltd. earned $0.00 per diluted share (EPS) in fiscal year 2025. This represents an increase of 100.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$75.2M

YoY-97.3%

Uxin Ltd. generated -$75.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 97.3% from the prior year.

Cash & Debt

$11.9M

YoY+267.3%

5Y CAGR-29.6%

Uxin Ltd. held $11.9M in cash against $1.4M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

64.89B

5Y CAGR+135.9%

Uxin Ltd. had 64.89B shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin

6.7%

YoY+0.8pp

5Y CAGR-49.9pp

Uxin Ltd.'s gross margin was 6.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the prior year.

Operating Margin

-5.4%

YoY+17.4pp

5Y CAGR+76.0pp

Uxin Ltd.'s operating margin was -5.4% in fiscal year 2025, reflecting core business profitability. This is up 17.4 percentage points from the prior year.

Net Margin

-8.1%

YoY+19.0pp

5Y CAGR+117.1pp

Uxin Ltd.'s net profit margin was -8.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 19.0 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$1.8M

YoY-62.1%

5Y CAGR-38.4%

Uxin Ltd. invested $1.8M in research and development in fiscal year 2025. This represents a decrease of 62.1% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$3.1M

YoY+74.7%

5Y CAGR-14.5%

Uxin Ltd. invested $3.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 74.7% from the prior year.

UXIN Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY19
Revenue	$463.3M+143.3%	$190.4M-36.5%	$299.8M+16.2%	$258.1M+157.2%	$100.3M-55.9%	$227.6M
Cost of Revenue	$432.3M+141.2%	$179.2M-39.5%	$296.1M+18.2%	$250.6M+143.7%	$102.8M+4.1%	$98.8M
Gross Profit	$30.9M+177.3%	$11.2M+201.2%	$3.7M-50.8%	$7.5M+402.6%	-$2.5M-101.9%	$128.8M
R&D Expenses	$1.8M-62.1%	$4.7M-14.7%	$5.5M-3.9%	$5.7M-49.5%	$11.3M-43.6%	$20.1M
SG&A Expenses	$12.8M-47.8%	$24.6M+2.6%	$24.0M+0.5%	$23.8M-43.8%	$42.4M-26.4%	$57.6M
Operating Income	-$24.8M+42.7%	-$43.3M+16.7%	-$52.0M-18.1%	-$44.0M+47.8%	-$84.3M+54.5%	-$185.2M
Interest Expense	$13.5M+55.8%	$8.7M+180.3%	$3.1M-52.4%	$6.5M-55.6%	$14.6M-9.3%	$16.1M
Income Tax	$6K-86.0%	$43K-18.9%	$53K+35.9%	$39K+680.0%	$5K+101.4%	-$366K
Net Income	-$37.5M+27.2%	-$51.6M-158.2%	-$20.0M+11.6%	-$22.6M+64.9%	-$64.3M+77.4%	-$285.1M
EPS (Diluted)	$0.00+100.0%	$-0.15-50.0%	$-0.10+69.7%	$-0.33-230.0%	$-0.10+52.4%	$-0.21

Metric	Q4'25	Q2'25	Q4'24	Q1'24	Q1'23	Q1'22	Q3'21	Q1'21
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

UXIN Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY19
Total Assets	$345.9M+19.6%	$289.2M+176.4%	$104.6M-47.0%	$197.4M+4.8%	$188.3M-75.6%	$771.6M
Current Assets	$106.4M+239.3%	$31.4M-23.6%	$41.0M-70.3%	$137.9M+8.5%	$127.1M-82.1%	$708.8M
Cash & Equivalents	$11.9M+267.3%	$3.2M-76.1%	$13.5M-33.2%	$20.2M-31.3%	$29.4M-57.1%	$68.5M
Inventory	$78.0M+409.8%	$15.3M-5.2%	$16.1M-76.0%	$67.2M+533.1%	$10.6M+437.2%	$2.0M
Accounts Receivable	$660K+128.4%	$289K+151.3%	$115K-12.2%	$131K-65.1%	$375K-94.1%	$6.4M
Goodwill	N/A	N/A	N/A	N/A	N/A	$1.4M
Total Liabilities	$330.8M+7.1%	$309.0M+6.5%	$290.0M-33.4%	$435.6M-11.6%	$492.9M-30.1%	$705.0M
Current Liabilities	$139.7M+14.0%	$122.6M+39.4%	$87.9M-57.1%	$204.9M+17.0%	$175.1M-59.2%	$429.1M
Long-Term Debt	$1.4M	N/A	$42.5M	N/A	N/A	N/A
Total Equity	-$33.0M+18.6%	-$40.6M+78.1%	-$185.4M+22.2%	-$238.2M+21.8%	-$304.6M-552.9%	$67.3M
Retained Earnings	-$2.8B-5.8%	-$2.7B-8.8%	-$2.5B+2.6%	-$2.5B-4.3%	-$2.4B-33.7%	-$1.8B

Metric	Q4'25	Q2'25	Q4'24	Q1'24	Q1'23	Q1'22	Q3'21	Q1'21
Total Assets	$345.9M+21.2%	$285.3M+6.7%	$267.4M-7.5%	$289.2M+176.4%	$104.6M-47.0%	$197.4M-4.1%	$205.9M+9.4%	$188.3M
Current Assets	$106.4M+70.3%	$62.5M+34.4%	$46.5M+48.3%	$31.4M-23.6%	$41.0M-70.3%	$137.9M-5.6%	$146.1M+14.9%	$127.1M
Cash & Equivalents	$11.9M+24.6%	$9.5M+177.0%	$3.4M+6.4%	$3.2M-76.1%	$13.5M-33.2%	$20.2M-40.0%	$33.6M+14.4%	$29.4M
Inventory	$78.0M+100.0%	$39.0M+37.3%	$28.4M+85.7%	$15.3M-5.2%	$16.1M-76.0%	$67.2M+48.5%	$45.3M+326.3%	$10.6M
Accounts Receivable	$660K+31.5%	$502K-11.8%	$569K+96.9%	$289K+151.3%	$115K-12.2%	$131K-74.6%	$515K+37.3%	$375K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$330.8M+17.1%	$282.6M-4.7%	$296.6M-4.0%	$309.0M+6.5%	$290.0M-33.4%	$435.6M-38.4%	$707.6M+43.6%	$492.9M
Current Liabilities	$139.7M+54.0%	$90.7M-13.1%	$104.4M-14.8%	$122.6M+39.4%	$87.9M-57.1%	$204.9M-57.8%	$485.7M+177.4%	$175.1M
Long-Term Debt	N/A	N/A	$7.4M	N/A	$42.5M	N/A	$36.2M	N/A
Total Equity	-$33.0M+17.0%	-$39.8M+21.1%	-$50.4M-24.3%	-$40.6M+78.1%	-$185.4M+22.2%	-$238.2M+52.5%	-$501.7M-64.7%	-$304.6M
Retained Earnings	-$2.8B-3.2%	-$2.8B-2.6%	-$2.7B0.0%	-$2.7B-8.8%	-$2.5B+2.6%	-$2.5B+7.8%	-$2.7B-13.1%	-$2.4B

UXIN Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY19
Operating Cash Flow	-$72.1M-98.4%	-$36.3M+0.6%	-$36.6M+72.6%	-$133.3M+22.2%	-$171.3M-0.1%	-$171.2M
Capital Expenditures	$3.1M+74.7%	$1.8M-63.6%	$4.8M+64.3%	$2.9M+4571.4%	$63K-99.1%	$6.7M
Free Cash Flow	-$75.2M-97.3%	-$38.1M+8.0%	-$41.4M+69.6%	-$136.2M+20.5%	-$171.4M+3.7%	-$177.9M
Investing Cash Flow	-$3.0M-92.7%	-$1.6M+66.3%	-$4.7M-76.3%	-$2.6M-103.9%	$67.6M+197.4%	-$69.4M
Financing Cash Flow	$83.2M+192.5%	$28.4M-18.6%	$34.9M-71.0%	$120.6M+506.2%	$19.9M+88.5%	$10.6M
Dividends Paid	$0	$0	$0	$0	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q2'25	Q4'24	Q1'24	Q1'23	Q1'22	Q3'21	Q1'21
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

UXIN Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY19
Gross Margin	6.7%+0.8pp	5.9%+4.6pp	1.2%-1.7pp	2.9%+5.4pp	-2.5%-59.1pp	56.6%
Operating Margin	-5.4%+17.4pp	-22.7%-5.4pp	-17.3%-0.3pp	-17.1%+67.0pp	-84.1%-2.7pp	-81.4%
Net Margin	-8.1%+19.0pp	-27.1%-20.4pp	-6.7%+2.1pp	-8.8%+55.3pp	-64.1%+61.2pp	-125.2%
Return on Equity	N/A	N/A	N/A	N/A	N/A	-423.9%
Return on Assets	-10.8%+7.0pp	-17.8%+1.3pp	-19.1%-7.6pp	-11.5%+22.7pp	-34.2%+2.8pp	-36.9%
Current Ratio	0.76+0.5	0.26-0.2	0.47-0.2	0.67-0.1	0.73-0.9	1.65
Debt-to-Equity	-10.02-2.4	-7.62-7.4	-0.23+1.6	-1.83-0.2	-1.62-12.1	10.48
FCF Margin	-16.2%+3.8pp	-20.0%-6.2pp	-13.8%+39.0pp	-52.8%+118.0pp	-170.8%-92.6pp	-78.1%

Metric	Q4'25	Q2'25	Q4'24	Q1'24	Q1'23	Q1'22	Q3'21	Q1'21
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	0.76+0.1	0.69+0.2	0.45+0.2	0.26-0.2	0.47-0.2	0.67+0.4	0.30-0.4	0.73
Debt-to-Equity	-10.02-2.9	-7.11-7.0	-0.15+7.5	-7.62-7.4	-0.23+1.6	-1.83-1.8	-0.07+1.5	-1.62
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$33.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.76), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Camping World CWH

$487.8M

Kingsway Finl KFS

$307.2M

Acv Auctions Inc. ACVA

$1.0B

Mister Car Wash Inc MCW

$2.3B

SunCar Technology Group Inc. SDA

$69.0M

Frequently Asked Questions

What is Uxin Ltd.'s annual revenue?

Uxin Ltd. (UXIN) reported $463.3M in total revenue for fiscal year 2025. This represents a 143.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Uxin Ltd.'s revenue growing?

Uxin Ltd. (UXIN) revenue grew by 143.3% year-over-year, from $190.4M to $463.3M in fiscal year 2025.

Is Uxin Ltd. profitable?

No, Uxin Ltd. (UXIN) reported a net income of -$37.5M in fiscal year 2025, with a net profit margin of -8.1%.

What is Uxin Ltd.'s EBITDA?

Uxin Ltd. (UXIN) had EBITDA of -$15.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Uxin Ltd. have?

As of fiscal year 2025, Uxin Ltd. (UXIN) had $11.9M in cash and equivalents against $1.4M in long-term debt.

What is Uxin Ltd.'s gross margin?

Uxin Ltd. (UXIN) had a gross margin of 6.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Uxin Ltd.'s operating margin?

Uxin Ltd. (UXIN) had an operating margin of -5.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Uxin Ltd.'s net profit margin?

Uxin Ltd. (UXIN) had a net profit margin of -8.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Uxin Ltd.'s free cash flow?

Uxin Ltd. (UXIN) generated -$75.2M in free cash flow during fiscal year 2025. This represents a -97.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Uxin Ltd.'s operating cash flow?

Uxin Ltd. (UXIN) generated -$72.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Uxin Ltd.'s total assets?

Uxin Ltd. (UXIN) had $345.9M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Uxin Ltd.'s capital expenditures?

Uxin Ltd. (UXIN) invested $3.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Uxin Ltd. spend on research and development?

Uxin Ltd. (UXIN) invested $1.8M in research and development during fiscal year 2025.

How many shares does Uxin Ltd. have outstanding?

Uxin Ltd. (UXIN) had 64.89B shares outstanding as of fiscal year 2025.

What is Uxin Ltd.'s current ratio?

Uxin Ltd. (UXIN) had a current ratio of 0.76 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Uxin Ltd.'s debt-to-equity ratio?

Uxin Ltd. (UXIN) had a debt-to-equity ratio of -10.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Uxin Ltd.'s return on assets (ROA)?

Uxin Ltd. (UXIN) had a return on assets of -10.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Uxin Ltd.'s cash runway?

Based on fiscal year 2025 data, Uxin Ltd. (UXIN) had $11.9M in cash against an annual operating cash burn of $72.1M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Uxin Ltd.'s debt-to-equity ratio negative or unusual?

Uxin Ltd. (UXIN) has negative shareholder equity of -$33.0M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Uxin Ltd.'s Piotroski F-Score?

Uxin Ltd. (UXIN) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Uxin Ltd.'s earnings high quality?

Uxin Ltd. (UXIN) has an earnings quality ratio of 1.92x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Uxin Ltd. cover its interest payments?

Uxin Ltd. (UXIN) has an interest coverage ratio of -1.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Uxin Ltd.?

Uxin Ltd. (UXIN) scores 14 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.